A retrospective real-world study of nimotuzumab combined with chemotherapy for first-line treatment of advanced pancreatic cancer: A single center propensity score matched analysis

被引：0
|
作者：
Wu, Y. [1 ]
Dong, X. [2 ]
Li, E. [1 ]
Fan, Y. [2 ]
Dong, D. [3 ]
Shi, Y. [3 ]
Wang, M. [4 ]
Yang, N. [4 ]
Ou, F. [4 ]
Wang, J. [4 ]
Yang, Y. [4 ]
机构：
[1] Xi An Jiao Tong Univ, Med Coll, Affiliated Hosp 1, Med Oncol Dept, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Oncol, Xian, Peoples R China
[3] Xi An Jiao Tong Univ, Med Oncol, Xian, Peoples R China
[4] Xi An Jiao Tong Univ, Med Oncol, Sch Med, Xian, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1678P
引用
收藏
页码：S920 / S920
页数：1
相关论文
共 50 条
  • [21] Clinical outcomes of first-line chemotherapy in locally advanced and metastatic pancreatic adenocarcinoma patients: Real-world experience
    Umpawan, N.
    Termsinsuk, P.
    Kaosombatwattana, U.
    Akewanlop, C.
    Korphaisarn, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S919 - S920
  • [22] Nineteen-year, real-world experience of first-line combination chemotherapy in patients with metastatic colorectal cancer: a propensity score analysis from southern Thailand
    Wonglhow, Jirapat
    Sathitruangsak, Chirawadee
    Dechaphunkul, Arunee
    Sunpaweravong, Patrapim
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (08)
  • [23] Second-line chemotherapy in advanced pancreatic cancer: A retrospective, single-center analysis
    Herrmann, T.
    Jaeger, D.
    Stremmel, W.
    Herrmann, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Capecitabine plus Cisplatin as First-Line Chemotherapy for Advanced Biliary Tract Cancer: A Retrospective Single-Center Study
    Woo, Sang Myung
    Lee, Woo Jin
    Han, Sung-Sik
    Park, Sang-Jae
    Kim, Tae Hyun
    Koh, Young Hwan
    Kim, Hyun Bum
    Hong, Eun Kyung
    Park, Joong-Won
    Kim, Chang-Min
    CHEMOTHERAPY, 2012, 58 (03) : 225 - 232
  • [25] A retrospective study of first-line combination chemotherapy in advanced colorectal cancer A Korean single-center experience.
    Lee, S.
    Park, J.
    Park, S.
    Kang, W.
    Lim, H.
    Park, Y.
    Park, K.
    Lee, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [26] Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer
    Blomstrand, Hakon
    Batra, Atul
    Cheung, Winson Y.
    Elander, Nils Oskar
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (09): : 787 - 799
  • [27] Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
    Pelicon, Veronika
    Cufer, Tanja
    Knez, Lea
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [28] PD-L1 Inhibitors Combined with Thoracic Radiotherapy in First-Line Treatment of Extensive Stage Small Cell Lung Cancer: A Propensity Score-Matched, Real -World Study
    Peng, J.
    Zhang, L.
    Wang, L.
    Feng, H.
    Yao, D.
    Meng, R.
    Liu, X.
    Li, X.
    Liu, N.
    Tan, B.
    Huang, Z.
    Li, S.
    Meng, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S127 - S128
  • [29] Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy in locally advanced cervical cancer: A multicenter real-world study
    Li, Jiwei
    Wu, Tao
    Cai, Manbo
    Xie, Changjun
    Ding, Sijuan
    Zou, Wen
    Wang, Jingjing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma
    Li, Qingqing
    Su, Tong
    Zhang, Xu
    Pan, Yanfeng
    Ma, Shengli
    Zhang, Lu
    Zhang, Xianqiang
    Gao, Xiaojuan
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3037 - 3046
12345